Access to anti-retroviral drugs, female in Togo
Togo: Access to anti-retroviral drugs, female was 96.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Togo, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Togo recorded 96.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 2.1% on the previous year and up 118.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Togo peaked at 96.0% in 2024 and was at its lowest, 0.0%, in 2000.
Togo ranks 14th of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Togo, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 2.0% | +100.0% |
| 2005 | 5.0% | +150.0% |
| 2006 | 6.0% | +20.0% |
| 2007 | 7.0% | +16.7% |
| 2008 | 10.0% | +42.9% |
| 2009 | 15.0% | +50.0% |
| 2010 | 24.0% | +60.0% |
| 2011 | 28.0% | +16.7% |
| 2012 | 36.0% | +28.6% |
| 2013 | 41.0% | +13.9% |
| 2014 | 44.0% | +7.3% |
| 2015 | 50.0% | +13.6% |
| 2016 | 61.0% | +22.0% |
| 2017 | 73.0% | +19.7% |
| 2018 | 74.0% | +1.4% |
| 2019 | 85.0% | +14.9% |
| 2020 | 90.0% | +5.9% |
| 2021 | 90.0% | +0.0% |
| 2022 | 86.0% | -4.4% |
| 2023 | 94.0% | +9.3% |
| 2024 | 96.0% | +2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.6% | 0.0% | 15.0% | 10 |
| 2010s | 51.6% | 24.0% | 85.0% | 10 |
| 2020s | 91.2% | 86.0% | 96.0% | 5 |
Countries ranked near Togo
More gender data for Togo
- Child population (UN estimates and projections) 4,049 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.27 % change on previous year (2030)
- Population 6,744 (2030)
- Working-age population (UN estimates and projections) 6,744 (2030)
- Population (UN estimates and projections), annual growth rate 2.58 % change on previous year (2030)
- Age population, age 00, female, interpolated 129,302 (2025)
- Age population, age 00, male, interpolated 131,980 (2025)
- Age population, age 01, female, interpolated 127,260 (2025)
- Age population, age 01, male, interpolated 129,478 (2025)
- Age population, age 02, female, interpolated 117,518 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Togo?
- Access to anti-retroviral drugs, female in Togo was 96.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Togo?
- The highest recorded value was 96.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Togo?
- The lowest recorded value was 0.0% in 2000.
- How does Togo rank for access to anti-retroviral drugs, female?
- Togo ranks 14th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Togo?
- Over the last ten years it is up 118.2%. The long-run trend across the full record is volatile.
- Where does this Togo data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.